Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 25	$ 10
Accounts receivable - trade (less allowance for doubtful accounts)	494	600
Unbilled revenue	319	446
Advances to money pool	106	54
Inventories	733	667
Current regulatory assets	365	354
Investments in Industrial Development Revenue Bonds	0
Current collateral assets	14	142
Other current assets	125	155
Total current assets	2,181	2,668
Property, Plant, and Equipment, Net	33,776	31,262
Investments and Other Assets:
Nuclear decommissioning trust fund	1,150	958
Goodwill	411	411
Regulatory assets	1,810	1,426
Pension and other postretirement benefits	581	411
Other assets	921	768
Total investments and other assets	4,873	3,974
TOTAL ASSETS	40,830	37,904
Current Liabilities:
Current maturities of long-term debt	849	340
Short-term debt	536	1,070
Accounts and wages payable	1,136	1,159
Customer deposits	176	115
Other current liabilities	648	682
Total current liabilities	3,345	3,366
Long-term Debt, Net	15,121	13,685
Deferred Credits and Other Liabilities:
Accumulated deferred income taxes and investment tax credits, net	4,176	3,804
Regulatory liabilities	5,512	5,309
Asset retirement obligations	772	763
Other deferred credits and liabilities	426	340
Total deferred credits and other liabilities	10,886	10,216
Commitments and Contingencies (Notes 2, 9, and 14)
Shareholders' Equity:
Common stock	3	3
Other paid-in capital, principally premium on common stock	7,216	6,860
Retained earnings	4,136	3,646
Accumulated other comprehensive loss	(6)	(1)
Total shareholders' equity	11,349	10,508
Noncontrolling Interests	129	129
Total equity	11,478	10,637
TOTAL LIABILITIES AND EQUITY	$ 40,830	$ 37,904